Select your country

Mark Keatley

Chief Financial Officer/CFO

Bio

I have served as Chief Financial Officer of STADA Arzneimittel AG since September 27, 2017.

I have over 20 years’ experience as a CFO of international companies, mainly in the generic pharmaceutical industry. My last CFO assignment prior to STADA was at the generic phama company Actavis, which grew its sales from approx. $500 million to approx. $2.5 billion during my seven years as CFO. After the successful sale of Actavis in 2012, I joined the strategy -consulting firm Albrecht Prock & Partners, providing advice on M&A, corporate finance, and performance improvement, and in this capacity I was part of the team advising Bain Capital and Cinven on the acquisition of STADA.

Previously I served as CFO of Famar, the European contract manufacturer, and Ardana Bioscience, a biotech company. My first position as CFO was at Ashanti Goldfields Corporation in Ghana, which was the first African company to be listed on the New York Stock Exchange. Earlier in my career, I worked at the International Finance Corporation in Washington DC, where I executed many financings and investments in the emerging markets.

I hold a Masters Degree from Cambridge University, UK, and an MBA from Stanford Gradua te School of Business, USA. I am happily married to a physician and we have three children. My wife and I are co-Founders of a trust that has raised over $5 million for medical ventures in Africa.

 

Download PDF